Viewing Study NCT00027261


Ignite Creation Date: 2025-12-24 @ 12:02 PM
Ignite Modification Date: 2025-12-30 @ 1:18 PM
Study NCT ID: NCT00027261
Status: COMPLETED
Last Update Posted: 2021-10-14
First Post: 2001-11-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module